Navigation Links
Bavarian Nordic Reports Successful Safety Data From Phase II Study With IMVAMUNE(R)
Date:11/6/2008

KVISTGARD, Denmark, November 6 /PRNewswire-FirstCall/ -- Bavarian Nordic has completed a clinical safety report from a large Phase II study with IMVAMUNE(R) in HIV infected subjects that confirms the excellent safety profile of IMVAMUNE(R). Within the next few days the safety report of this study will be submitted to the FDA and this will trigger a USD 25 million milestone payment under the RFP-3 contract. The clinical safety report constitutes a major part of the data package that will be used to potentially support the use of IMVAMUNE(R) in a declared emergency.

In support of using IMVAMUNE(R) as a smallpox vaccine in individuals otherwise contraindicated to receive conventional vaccinia vaccines, Bavarian Nordic has performed a large Phase II study in HIV infected subjects with CD4 counts between 200 and 750 cells/microl to compare the safety to healthy subjects.

The safety report from this study, which represents an essential part of the EUA data package, includes safety data from over 300 HIV infected and 86 healthy subjects, all of whom had no history of prior smallpox vaccination. The low number of adverse events confirmed the favourable safety profile of IMVAMUNE(R) in vaccinia-naive HIV infected subjects with varying degrees of immune suppression. Indeed, there was no difference in adverse events between the healthy and HIV infected subjects, even in the most immune compromised patients (CD4 counts greater than or equal to 200-350 cells/microl). IMVAMUNE(R) has now been tested in more than 2,200 people in 11 completed or on-going clinical studies, which includes a large proportion (more than 750) of immune-compromised people i.e. HIV infected or diagnosed with Atopic Dermatitis (AD) who are excluded from vaccination with traditional smallpox vaccines.

The complete data set from this trial is expected to be reported in the second half of 2009. The final report will include data on immunogenicity as well as long-term (6-month) safe
'/>"/>

SOURCE Bavarian Nordic A/S
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine
2. Bavarian Nordic Enters Clinical Trials with HIV Multiantigen Vaccine
3. Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Next Generation Oxazolidinone at 2008 ICAAC/IDSA Joint Meeting
4. Paratek Reports Positive Phase 2 Clinical Data on its New Antibiotic PTK 0796 in Late Breaker Presentation at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
5. Novexel Reports Positive Phase II Trial Results With NXL103 in Adult Patients With Community Acquired Pneumonia
6. Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio
7. Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting
8. Alimera Reports Results From the Six-Month Interim Readout of the Human PK Iluvien(TM) Study
9. BioView Reports Interim Results of Early Detection Lung Cancer Diagnostic Test
10. Bioheart Reports Promising Results From Preclinical Study of Adipose-Derived Acute Cell Therapy
11. MannKind Reports Positive Data from a Phase 3 Clinical Study of Technosphere Insulin in Type 1 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... Sept. 30, 2014 In 2011, approximately 5.1 ... abused prescription pain relievers (e.g. opioids). 1 ... treatment, which entails the use of buprenorphine, buprenorphine/naloxone, naltrexone ... are important when developing and improving care management programs, ... manager Prime Therapeutics LLC (Prime). ...
(Date:9/30/2014)... , Sept. 30, 2014 Organovo Holdings, ... company focused on delivering breakthrough 3D bioprinting technology, ... been selected as a finalist in the Diagnostics ... Innovative New Product Awards, sponsored by CONNECT. CONNECT, a ... technology and life sciences products in ...
(Date:9/30/2014)... September 30, 2014 , ... feature in-store events will change the way retail pharmaceutical ... the way we use and view pharmacies, Health First ... By catering to the very trendy public demands of ... of in-store events with various activities for both children ...
Breaking Medicine Technology:Studies show cost and use of opioid dependence treatment are increasing, spurring the need for care management programs 2Studies show cost and use of opioid dependence treatment are increasing, spurring the need for care management programs 3Organovo Inc. Selected As A Finalist In 27th Annual CONNECT Most Innovative New Product Awards 2Organovo Inc. Selected As A Finalist In 27th Annual CONNECT Most Innovative New Product Awards 3Health First Pharmacy Redefines 'Pharmacy Retail Experience' 2Health First Pharmacy Redefines 'Pharmacy Retail Experience' 3
... SAN RAMON, Calif., Nov. 29, 2011 Odyssey ... biologically-relevant pathways in human cells, announced today that ... a laser-based confocal imaging platform from GE Healthcare, ... Odyssey Thera applies a systems ...
... Nov. 29, 2011 A new study in The ... a novel mechanism that cancer cells may use to escape ... cells induce tumor cell resistance to cytotoxic T cells in ... Center in Tampa, Fla., shows that a specific type of ...
Cached Medicine Technology:Odyssey Thera is First to Install Next Generation High-Content Imaging Capability 2New Study Points to Novel Mechanism by Which Tumors Escape Recognition by the Immune System 2New Study Points to Novel Mechanism by Which Tumors Escape Recognition by the Immune System 3
(Date:9/30/2014)... Asheville, North Carolina (PRWEB) September 30, 2014 ... cloud readiness and IT Infrastructure analytics across data ... announced it has achieved an important milestone of ... problems and plan for important projects such as ... workload migrations. , The strong customer engagement ...
(Date:9/30/2014)... Washington DC. (PRWEB) September 30, 2014 ... has developed Lyricz iPhone App for another great social ... release of LYRICZ App for iPhone®, iPad®, and iPod ... 30 second snippets of music from their pre-populated ITunes ... associate the chosen song’s album art or photo of ...
(Date:9/30/2014)... Albany, New York (PRWEB) September 30, 2014 ... Research, a U.S.-based market intelligence agency states that the ... a value of USD 18.5 billion by the end ... was valued at USD 10.3 billion in 2012, will ... develop into a USD 18.5 billion worth market by ...
(Date:9/30/2014)... 2014 MyServer2Go.com made an ... Best VPS Hosting this year for its quality VPS ... price. , MyServer2Go.com is a professional and targeted ... services. And this announcement will help webmasters find the ... MyServer2Go.com, Arvixe ( http://www.arvixe.com ) is one of the ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 Speaking on ... OMICS Group observed ‘Nursing Conference’ as a remarkable event, ... and medium medical and clinical research and diagnostic companies, ... conference as a perfect platform to share experience, foster ... around the world. Nursing Conference is a forum to ...
Breaking Medicine News(10 mins):Health News:RISC Networks Becomes First SaaS Cloud Readiness and IT Infrastructure Analytics Vendor to Surpass Milestone of 5,000 Engagements 2Health News:RISC Networks Becomes First SaaS Cloud Readiness and IT Infrastructure Analytics Vendor to Surpass Milestone of 5,000 Engagements 3Health News:LYRICZ App for iPhone®, Helps You Share Images with Music to Inspire and Influence 2Health News:Global Medical Imaging Reagents Market Segment up to 2019: Transparency Market Research 2Health News:Global Medical Imaging Reagents Market Segment up to 2019: Transparency Market Research 3Health News:Arvixe Is Named Best VPS Hosting by MyServer2Go.com 2Health News:Exploring New Possibilities to Take Nursing Profession to Great Heights 2Health News:Exploring New Possibilities to Take Nursing Profession to Great Heights 3
... way deter the elders from chatting or surfing the Internet ... net on par// with the youngsters. ,The survey conducted ... Marketing Services has revealed that senior netizens are a fast-growing ... million by 2008. ,These seniors - who number ...
... very common in North America with an estimated 400,000 people ... these //people have their hearts pumping again and only 6 ... causes of death after the heart is restarted is brain ... Society for Academic Emergency Medicine Annual Meeting, May 18-21, in ...
... get themselves screened for HIV, city-run medical clinics have relaxed ... the new rule, counseling sessions and written informed consent is ... is a verbal consent from the patient. ,This ... relaxed with respect to consent and counseling. Two hospitals and ...
... have issued a warning to drug users about the quality ... is being sold on the west coast// of Scotland has ... the beginning of this year there has been 82 inquiries ... same period last year. The police have said that not ...
... say may fight two dangerous germs that bedevil hospitals//. ... Laboratories and his colleagues looked at 250,000 extracts from ... from around the world, the health portal HealthDay News ... African soil, which they say could fight staph an ...
... Following high incidence of a potentially dangerous infection associated ... Bausch & Lomb//, those in Hong Kong, US and ... controversial product has been withdrawn from sales. ... product. However the company has been unable to claim ...
Cached Medicine News:Health News:Elders Too Are Keen To Chat On Internet On Par With Youngsters 2Health News:Survival After Cardiac Arrest Is Aided By Cooling 2
... in the field of hammertoe implants with the ... grade silicone, these durable and lasting implants will ... flexibility while maintaining correct toe length and shape. ... Lengths are determined by the surgeon for each ...
... Implant (KGTI) system offers the latest technology ... MPJ. The implant system is anatomically designed ... ,The KGTI is the most advanced reconstructive ... on the market today. The system consists ...
... has been approved for use as an ... seizures in adults and adolescents over 12 ... that are refractory to antiepileptic medications. This ... controlled, clinical trials. Efficacy, measured as median ...
Ad-Techs Spinal Electrodes are intended for intraoperative monitoring of Evoked Potentials (EPs) of the descending pathway during spinal surgery. They are offered with 2 or 3 platinum contacts....
Medicine Products: